Skip to main content
. 2014 Mar 28;2014(3):CD003336. doi: 10.1002/14651858.CD003336.pub3

Comparison 1. Quasi‐randomised studies of warfarin versus control in patients with chronic heart failure.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 All cause deaths 3 942 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.48 [0.32, 0.71]
2 Cardiovascular deaths (stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism) and sudden deaths 3 942 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.34 [0.24, 0.47]
3 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism) 3 942 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.24 [0.14, 0.41]
4 Major bleeding events 2 645 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.52 [0.56, 4.10]